Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
Related posts
-
Will data center boom strain Illinois’ power grids, force rate hikes?
Illinois and the suburbs have been at the forefront of the national data center boom, but... -
Cleaning woman accused of stealing jewelry from 3 clients in Glen Ellyn
A cleaning woman has been charged with stealing $20,000 worth of jewelry from three clients in... -
Mount Prospect improving look at village, business park entrances
Mount Prospect is creating a “friendlier” look at its entrances to the downtown and the south...